Disease burden and symptom structure of autism in neurofibromatosis type 1: A study of the international NF1-ASD consortium team (INFACT)

JAMA Psychiatry

Volumn 73, Issue 12, 2016, Pages 1276-1284

  Morris, Stephanie M ^a   Acosta, Maria T ^b   Garg, Shruti ^c,d,e   Green, Jonathan ^c,d,e   Huson, Susan ^e   Legius, Eric ^f   North, Kathryn N ^g,h   Payne, Jonathan M ^g,h   Plasschaert, Ellen ^f   Frazier, Thomas W ⁱ   Weiss, Lauren A ^j   Zhang, Yi ^a   Gutmann, David H ^a   Constantino, John N ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

^d UNIVERSITY OF MANCHESTER   (United Kingdom)

^e MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

^f UNIVERSITY OF LEUVEN   (Belgium)

^g ROYAL CHILDREN'S HOSPITAL   (Australia)

^h UNIVERSITY OF MELBOURNE   (Australia)

ⁱ LERNER RESEARCH INSTITUTE   (United States)

^j UNIVERSITY OF CALIFORNIA   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; ATTENTION DEFICIT DISORDER; AUSTRALIA; AUTISM; BELGIUM; CHILD; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROFIBROMATOSIS TYPE 1; PHENOTYPE; RATING SCALE; SOCIAL RESPONSIVENESS SCALE; TERTIARY CARE CENTER; UNITED KINGDOM; UNITED STATES; AUTISM SPECTRUM DISORDER; CLINICAL TRIAL; COMORBIDITY; COST OF ILLNESS; GENETIC PREDISPOSITION; GENETICS; INTERNATIONAL COOPERATION; MIDDLE AGED; MULTICENTER STUDY; NEUROFIBROMATOSES; PRESCHOOL CHILD; PSYCHOLOGY; QUANTITATIVE TRAIT LOCUS; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AUTISM SPECTRUM DISORDER; CHILD; CHILD, PRESCHOOL; COMORBIDITY; COST OF ILLNESS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTERNATIONALITY; MALE; MIDDLE AGED; NEUROFIBROMATOSES; QUANTITATIVE TRAIT LOCI; YOUNG ADULT;

EID: 85011419253     PISSN: 2168622X     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamapsychiatry.2016.2600     Document Type: Article

References (45)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. Arlington, VA: American Psychiatric Association; 2013.
2. Christensen DL, Baio J, Van Naarden Braun K, et al; Centers for Disease Control and Prevention (CDC). Prevalence and characteristics of autism spectrum disorder among children aged 8 years-Autism and Developmental Disabilities Monitoring Network, 11 sites, United States, 2012. MMWR Surveill Summ. 2016;65(3):1-23.
3. Pisula E, Danielewicz D, Kawa R, PisulaW. Autism spectrum quotient, coping with stress and quality of life in a non-clinical sample-an exploratory report. Health Qual Life Outcomes. 2015;13:173.
4. Lee SH, Ripke S, Neale BM, et al; Cross-Disorder Group of the Psychiatric Genomics Consortium; International Inflammatory Bowel Disease Genetics Consortium (IIBDGC). Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat Genet. 2013;45(9):984-994.
5. Sandin S, Lichtenstein P, Kuja-Halkola R, Larsson H, Hultman CM, Reichenberg A. The familial risk of autism. JAMA. 2014;311(17):1770-1777.
6. National Institutes of Health Consensus Development Conference statement: neurofibromatosis. Arch Neurol. 1988;45(5):575-578.
7. Uusitalo E, Hammais A, Palonen E, et al. Neurofibromatosis type 1 gene mutation analysis using sequence capture and high-throughput sequencing. Acta Derm Venereol. 2014;94(6):663-666.
8. Constantino JN, Zhang Y, Holzhauer K, et al. Distribution and within-family specificity of quantitative autistic traits in patients with neurofibromatosis type 1. J Pediatr. 2015;167(3): 621-626.
9. Adviento B, Corbin IL, Widjaja F, et al. Autism traits in the RASopathies. J Med Genet. 2014;51(1): 10-20.
10. Walsh KS, Vélez JI, Kardel PG, et al. Symptomatology of autism spectrum disorder in a population with neurofibromatosis type 1. Dev Med Child Neurol. 2013;55(2):131-138.
11. Plasschaert E, Descheemaeker MJ, Van Eylen L, Noens I, Steyaert J, Legius E. Prevalence of autism spectrum disorder symptoms in children with neurofibromatosis type 1. Am J Med Genet B Neuropsychiatr Genet. 2015;168(1):72-80.
12. Garg S, Lehtonen A, Huson SM, et al. Autism and other psychiatric comorbidity in neurofibromatosis type 1: evidence from a population-based study. Dev Med Child Neurol. 2013;55(2):139-145.
13. Garg S, Green J, Leadbitter K, et al. Neurofibromatosis type 1 and autism spectrum disorder. Pediatrics. 2013;132(6):e1642-e1648.
14. Hyman SL, Shores A, North KN. The nature and frequency of cognitive deficits in children with neurofibromatosis type 1. Neurology. 2005;65(7): 1037-1044.
15. Payne JM, Hyman SL, Shores EA, North KN. Assessment of executive function and attention in children with neurofibromatosis type 1: relationships between cognitive measures and real-world behavior. Child Neuropsychol. 2011;17(4): 313-329.
16. Constantino JN, Gruber CP. Social Responsiveness Scale. 2nd ed. Los Angeles, CA: Western Psychological Services; 2012.
17. Constantino JN, Davis SA, Todd RD, et al. Validation of a brief quantitative measure of autistic traits: comparison of the Social Responsiveness Scale with the Autism Diagnostic Interview- Revised. J Autism Dev Disord. 2003;33(4):427-433.
18. Conners CK. Conners. 3rd ed. Toronto, ON: Multi-Health Systems; 2008.
19. Conners CK, Ehrhardt D, Sparrow E. CAARS Adult ADHD Rating Scales. Toronto, ON: Multi-Health Systems; 1999.
20. Conners CK. Conners Parent Rating Scale- Revised. Toronto, ON: Multi-Health Systems; 1997.
21. Conners CK. Conners ADHD/DSM-IV Scales. North Tanawanda, NY: Multi-Health Systems; 1997.
22. Conners CK, Sitarenios G, Parker JD, Epstein JN. The revised Conners' Parent Rating Scale (CPRS-R): factor structure, reliability, and criterion validity. J Abnorm Child Psychol. 1998;26(4):257-268.
23. Muthen LK, Muthen BO. Mplus User's Guide. 7th ed. Los Angeles, CA: Muthen & Muthen; 1998-2012.
24. Frazier TW, Ratliff KR, Gruber C, Zhang Y, Law PA, Constantino JN. Confirmatory factor analytic structure and measurement invariance of quantitative autistic traits measured by the Social Responsiveness Scale-2. Autism. 2014;18(1):31-44.
25. Nylund KL, Asparouhoy T, Muthen BO. Deciding on the number of classes in latent class analysis and growth mixture modeling: A Monte Carlo simulation study. Struct Equ Modeling. 2007; 14(4):535-569.
26. Yang C. Evaluating latent class analysis models in qualitative phenotype identification. Comput Stat Data Anal. 2006;50:1090-1104.
27. IBM SPSS Statistics (for Windows) [computer program]. Version 23.0. Armonk, NY: IBM Corp; 2015.
28. Ramtekkar UP, Reiersen AM, Todorov AA, Todd RD. Sex and age differences in attention-deficit/ hyperactivity disorder symptoms and diagnoses: implications for DSM-V and ICD-11. J AmAcad Child Adolesc Psychiatry. 2010;49(3):217-228.
29. Constantino JN, Gruber CP, Davis S, Hayes S, Passanante N, Przybeck T. The factor structure of autistic traits. J Child Psychol Psychiatry. 2004;45 (4):719-726.
30. Wechsler D. TheWechsler Intelligence Scale for Children. 3rd ed. San Antonio, TX: Psychological Corp; 1991.
31. Wechsler D.Wechsler Abbreviated Scale of Intelligence. New York, NY: Psychological Corp, Harcourt Brace & Co; 1999.
32. Constantino JN, Todd RD. Autistic traits in the general population: A twin study. Arch Gen Psychiatry. 2003;60(5):524-530.
33. Constantino JN, Todd RD. Intergenerational transmission of subthreshold autistic traits in the general population. Biol Psychiatry. 2005;57(6): 655-660.
34. Frazier TW, Thompson L, Youngstrom EA, et al. A twin study of heritable and shared environmental contributions to autism. J Autism Dev Disord. 2014; 44(8):2013-2025.
35. Jacquemont S, Coe BP, Hersch M, et al. A higher mutational burden in females supports a "female protective model" in neurodevelopmental disorders. Am J Hum Genet. 2014;94(3):415-425.
36. Diggs-Andrews KA, Brown JA, Gianino SM, Rubin JB,Wozniak DF, Gutmann DH. Sex is a major determinant of neuronal dysfunction in neurofibromatosis type 1. Ann Neurol. 2014;75(2): 309-316.
37. Constantino JN, Frazier TW. The observed association between autistic severity measured by the Social Responsiveness Scale (SRS) and general psychopathology-a response to Hus et al (2013). J Child Psychol Psychiatry. 2013;54(6):695-697.
38. Kamio Y, Inada N, Moriwaki A, et al. Quantitative autistic traits ascertained in a national survey of 22 529 Japanese schoolchildren. Acta Psychiatr Scand. 2013;128(1):45-53.
39. Constantino JN, Lavesser PD, Zhang Y, Abbacchi AM, Gray T, Todd RD. Rapid quantitative assessment of autistic social impairment by classroom teachers. J AmAcad Child Adolesc Psychiatry. 2007;46(12):1668-1676.
40. Garg S, Plasschaert E, Descheemaeker MJ, et al. Autism spectrum disorder profile in neurofibromatosis type I. J Autism Dev Disord. 2015;45(6):1649-1657.
41. Constantino JN, Hudziak JJ, Todd RD. Deficits in reciprocal social behavior in male twins: evidence for a genetically independent domain of psychopathology. J AmAcad Child Adolesc Psychiatry. 2003;42(4):458-467.
42. Duvekot J, van der Ende J, Constantino JN, Verhulst FC, Greaves-Lord K. Symptoms of autism spectrum disorder and anxiety: shared familial transmission and cross-assortative mating. J Child Psychol Psychiatry. 2016;57(6):759-769.
43. Hoekstra RA, Bartels M, Verweij CJ, Boomsma DI. Heritability of autistic traits in the general population. Arch Pediatr Adolesc Med. 2007;161(4): 372-377.
44. Rojnueangnit K, Xie J, Gomes A, et al. High incidence of Noonan syndrome features including short stature and pulmonic stenosis in patients carrying NF1 missense mutations affecting p.Arg1809: genotype-phenotype correlation. Hum Mutat. 2015;36(11):1052-1063.
45. Toonen JA, Anastasaki C, Smithson LJ, et al. NF1 germline mutation differentially dictates optic glioma formation and growth in neurofibromatosis-1. Hum Mol Genet. 2016;25(9): 1703-1713.